Business Description
Kiromic BioPharma Inc
NAICS : 541714
SIC : 2833
ISIN : US4976342042
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | -0.42 | |||||
Debt-to-Equity | -2.59 | |||||
Debt-to-EBITDA | -0.81 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 50.5 | |||||
3-Year EPS without NRI Growth Rate | 56.4 | |||||
3-Year FCF Growth Rate | 27.2 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -59.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.35 | |||||
Quick Ratio | 0.35 | |||||
Cash Ratio | 0.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -72.7 | |||||
Shareholder Yield % | -193.12 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -167.8 | |||||
ROIC % | -109.98 | |||||
3-Year ROIIC % | -3.62 | |||||
ROC (Joel Greenblatt) % | -244.63 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.64 | |||||
EV-to-Forward-EBIT | -0.17 | |||||
EV-to-EBITDA | -0.72 | |||||
EV-to-Forward-EBITDA | -0.18 | |||||
EV-to-FCF | -0.48 | |||||
Earnings Yield (Greenblatt) % | -156.25 | |||||
FCF Yield % | -942.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kiromic BioPharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 51.3 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | -59.77 | ||
52-Week Range (€) | 3.645 - 15.3 | ||
Shares Outstanding (Mil) | 1.18 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kiromic BioPharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kiromic BioPharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Kiromic BioPharma Inc Frequently Asked Questions
What is Kiromic BioPharma Inc(FRA:5JU0)'s stock price today?
When is next earnings date of Kiromic BioPharma Inc(FRA:5JU0)?
Does Kiromic BioPharma Inc(FRA:5JU0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |